<DOC>
	<DOC>NCT00547560</DOC>
	<brief_summary>To assess the safety and tolerability of ascending, multiple, oral doses of GSI-953 in healthy elderly subjects.</brief_summary>
	<brief_title>Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population</brief_title>
	<detailed_description />
	<criteria>Men or women, greater than or equal to 65 years of age. Women of nonchildbearing potential (WONCP) may be included if they are either surgically sterile (hysterectomy and/or oophorectomy) or postmenopausal for greater than or equal to 1 year (with FSH greater than or equal to 38 mIU/mL) and must have a negative pregnancy test result within 48 hours before administration of test article. Women who are surgically sterile must provide documentation of the procedure by an operative report or by ultrasound. Body mass index (BMI) in the range of 18.0 to 30.0 kg/m2 and body weight &gt;50 kg.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Alzheimer Disease</keyword>
</DOC>